Humoral and cell-mediated immune response to the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with cancer on active treatment: Focus on wild type, Delta and Omicron strains - Lasagna, Angioletta; Cassaniti, Irene; Bergami, Federica; Lilleri, Daniele; Percivalle, Elena; Quaccini, Mattia; Alessio, Niccolò; Comolli, Giuditta; Sarasini, Antonella; Camilla, Josè; Ferrari, Alessandro; Arena, Francesca; et al. (Journal of clinical oncology, 2022)